Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada

被引:115
作者
Speert, DP
Campbell, ME
Henry, DA
Milner, R
Taha, F
Gravelle, A
Davidson, AGF
Wong, LTK
Mahenthiralingam, E
机构
[1] Univ British Columbia, Dept Pediat, Div Infect Dis & Immunol, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Pediat, Div Biochem Dis, Vancouver, BC V5Z 1M9, Canada
[3] Childrens & Womens Hosp British Columbia, British Columbia Inst Childrens & Womens Hlth, Vancouver, BC, Canada
[4] Childrens & Womens Hosp British Columbia, Cyst Fibrosis Clin, Vancouver, BC, Canada
关键词
cystic fibrosis; epidemiology; Pseudomonas aeruginosa;
D O I
10.1164/rccm.2203011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pseudomonas aeruginosa is the most common respiratory pathogen in patients with cystic fibrosis (CF), but the predominant mechanism by which it is acquired is controversial. To determine the frequency of patient-to-patient spread, we evaluated A aeruginosa isolates from 174 patients treated at the CIF clinics in Vancouver, BC, Canada, since 1981. Multiple isolates were obtained from each patient and genetically typed by random amplified polymorphic DNA and pulsed field gel electrophoresis analyses. A total of 157 genetic types of P. aeruginosa was identified, 123 of which were unique to individual patients. A total of 34 types was shared by more than one patient; epidemiologic evidence linked these individuals only in the cases of 10 sibships and I pair of unrelated patients. We conclude that there is an extremely low risk in Vancouver for patients with CIF to acquire P. aeruginosa from other Patients. It appears that prolonged close contact, such as occurs between siblings, is necessary for patient-to-patient spread. The major source of acquisition of P. aeruginosa in CIF appears to be from the environment. Considering these observations, we do not recommend segregation of patients with CIF on the basis of their colonization status with P. aeruginosa.
引用
收藏
页码:988 / 993
页数:6
相关论文
共 31 条
  • [1] Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa
    Campbell, M
    Mahenthiralingam, E
    Speert, DP
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (12) : 4614 - 4615
  • [2] Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
    Cheng, K
    Smyth, RL
    Govan, JRW
    Doherty, C
    Winstanley, C
    Denning, N
    Heaf, DP
    vanSaene, H
    Hart, CA
    [J]. LANCET, 1996, 348 (9028) : 639 - 642
  • [3] FARRELL PM, 1997, PEDIATRICS, V100, P21
  • [4] Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
    Goldman, MJ
    Anderson, GM
    Stolzenberg, ED
    Kari, UP
    Zasloff, M
    Wilson, JM
    [J]. CELL, 1997, 88 (04) : 553 - 560
  • [5] Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
    Govan, JRW
    Deretic, V
    [J]. MICROBIOLOGICAL REVIEWS, 1996, 60 (03) : 539 - +
  • [6] Govan JRW, 2000, J ROY SOC MED, V93, P40
  • [7] PSEUDOMONAS-AERUGINOSA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS - A CLASS OF SERUM-SENSITIVE, NONTYPABLE STRAINS DEFICIENT IN LIPOPOLYSACCHARIDE-O SIDE-CHAINS
    HANCOCK, REW
    MUTHARIA, LM
    CHAN, L
    DARVEAU, RP
    SPEERT, DP
    PIER, GB
    [J]. INFECTION AND IMMUNITY, 1983, 42 (01) : 170 - 177
  • [8] Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic
    Jones, AM
    Govan, JRW
    Doherty, CJ
    Dodd, ME
    Isalska, BJ
    Stanbridge, TN
    Webb, AK
    [J]. LANCET, 2001, 358 (9281) : 557 - 558
  • [9] KELLY NM, 1982, LANCET, V2, P688
  • [10] Burkholderia cepacia - Management issues and new insights
    LiPuma, JJ
    [J]. CLINICS IN CHEST MEDICINE, 1998, 19 (03) : 473 - +